M Grunert

773 total citations
19 papers, 349 citations indexed

About

M Grunert is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, M Grunert has authored 19 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in M Grunert's work include Cell death mechanisms and regulation (4 papers), Cancer-related Molecular Pathways (3 papers) and RNA Interference and Gene Delivery (2 papers). M Grunert is often cited by papers focused on Cell death mechanisms and regulation (4 papers), Cancer-related Molecular Pathways (3 papers) and RNA Interference and Gene Delivery (2 papers). M Grunert collaborates with scholars based in Germany, United States and Switzerland. M Grunert's co-authors include Irmela Jeremias, Harald Ehrhardt, Franziska Wachter, Sibylle Gündisch, Arnd Kieser, Marion Subklewe, Karsten Spiekermann, Klaus H. Metzeler, Wolfgang Hiddemann and Michela Carlet and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

M Grunert

16 papers receiving 345 citations

Peers

M Grunert

IMMUN

HEMAT

ONCOL

Michael R. Garbati United States

Somayeh S. Tarighat United States

N. H. Russell United Kingdom

M Misago Japan

Claudette M. Comeau United States

J Spielman United States

Marianne Arnhold Germany

S Murao Japan

Lily Sun United States

Chelsea M. Black United States

Michael R. Garbati United States

M Grunert

162 ×0.7

103 ×1.1

IMMUN

59 ×0.9

HEMAT

44 ×0.7

ONCOL

68 ×1.7

Citations per year, relative to M Grunert M Grunert (= 1×) peers Michael R. Garbati

Countries citing papers authored by M Grunert

Since Specialization

Citations

This map shows the geographic impact of M Grunert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Grunert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Grunert more than expected).

Fields of papers citing papers by M Grunert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Grunert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Grunert. The network helps show where M Grunert may publish in the future.

Co-authorship network of co-authors of M Grunert

This figure shows the co-authorship network connecting the top 25 collaborators of M Grunert. A scholar is included among the top collaborators of M Grunert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Grunert. M Grunert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Vick, Binje, Michela Carlet, Christina Krupka, et al.. (2015). An Advanced Preclinical Mouse Model for Acute Myeloid Leukemia Using Patients' Cells of Various Genetic Subgroups and In Vivo Bioluminescence Imaging. PLoS ONE. 10(3). e0120925–e0120925. 48 indexed citations

Zhang, Siwei, Binje Vick, M Grunert, et al.. (2015). Anti-leukemic effects of the V-ATPase inhibitor Archazolid A. Oncotarget. 6(41). 43508–43528. 24 indexed citations

Metzeler, Klaus H., Tobias Herold, Michela Carlet, et al.. (2014). Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia. Leukemia. 29(4). 828–838. 58 indexed citations

Jeremias, Irmela, et al.. (2014). TRAIL–Receptor Costimulation Inhibits Proximal TCR Signaling and Suppresses Human T Cell Activation and Proliferation. The Journal of Immunology. 193(8). 4021–4031. 34 indexed citations

Ehrhardt, Harald, et al.. (2013). Activation of DNA damage response by antitumor therapy counteracts the activity of vinca alkaloids.. PubMed. 33(12). 5273–87. 1 indexed citations

Ehrhardt, Harald, Franziska Wachter, M Grunert, & Irmela Jeremias. (2013). Cell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosis. Cell Death and Disease. 4(6). e661–e661. 39 indexed citations

Wachter, Franziska, M Grunert, Cristina Blaj, et al.. (2013). Impact of the p53 status of tumor cells on extrinsic and intrinsic apoptosis signaling. Cell Communication and Signaling. 11(1). 27–27. 13 indexed citations

Grunert, M, et al.. (2012). The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL. Cell Death and Disease. 3(10). e414–e414. 47 indexed citations

Alves, Catarina Castro, Nadia Terziyska, M Grunert, et al.. (2012). Leukemia-initiating cells of patient-derived acute lymphoblastic leukemia xenografts are sensitive toward TRAIL. Blood. 119(18). 4224–4227. 16 indexed citations

10.

Pauly, Barbara, Tanja Popp, M Grunert, et al.. (2010). The molecular cell death machinery in the simple cnidarian Hydra includes an expanded caspase family and pro- and anti-apoptotic Bcl-2 proteins. Cell Research. 20(7). 812–825. 56 indexed citations

11.

Grunert, M, et al.. (1970). [Associated chemical and microbiological studies on the antitubercular properties of ethionamide sulfoxide].. PubMed. 133(1). 406–8. 1 indexed citations

12.

Grunert, M, et al.. (1968). Veränderungen des Äthioniamides und seines Sulfoxydes in vitro. Lung. 138(1). 68–82. 1 indexed citations

13.

Grunert, M, et al.. (1968). [Changes in the ethioniamide and its sulfoxides in vitro].. PubMed. 138(1). 68–82. 1 indexed citations

14.

Grunert, M, et al.. (1968). [Metabolism of hard-soluble antitubercular agents].. PubMed. 128(1). 252–4.

15.

Grunert, M, et al.. (1967). [On the fate of tuberculostatics in macro- and microorganisms].. PubMed. 126(1). 106–30. 1 indexed citations

16.

Grunert, M, et al.. (1967). [On the metabolism of ethionamide and its sulfoxide in the macroorganism].. PubMed. 17(4). 411–5. 4 indexed citations

17.

Grunert, M, et al.. (1965). [ON THE METABOLISM OF ETHIONAMIDE AFTER INTRAVENOUS ADMINISTRATION].. PubMed. 15. 193–7. 1 indexed citations

18.

Grunert, M, et al.. (1964). Zum Stoffwechsel des Äthioniamids. Die Naturwissenschaften. 51(13). 316–316. 2 indexed citations

19.

Grunert, M, et al.. (1962). Zur Frage der ?Restreduktion? bei der Verg�rung von Mono- und Oligosacchariden durch Pre�hefe. European Food Research and Technology. 119(1). 1–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact